Literature DB >> 21356390

Tumor exosome-mediated MDSC activation.

Gregoire Mignot, Fanny Chalmin, Sylvain Ladoire, Cédric Rébé, François Ghiringhelli.   

Abstract

Mesh:

Substances:

Year:  2011        PMID: 21356390      PMCID: PMC3069877          DOI: 10.1016/j.ajpath.2010.11.078

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


× No keyword cloud information.
  15 in total

1.  Human tumor-derived exosomes selectively impair lymphocyte responses to interleukin-2.

Authors:  Aled Clayton; J Paul Mitchell; Jacquelyn Court; Malcolm D Mason; Zsuzsanna Tabi
Journal:  Cancer Res       Date:  2007-08-01       Impact factor: 12.701

Review 2.  Human tumor-derived vs dendritic cell-derived exosomes have distinct biologic roles and molecular profiles.

Authors:  Eva Wieckowski; Theresa L Whiteside
Journal:  Immunol Res       Date:  2006       Impact factor: 2.829

3.  Prostaglandin E2 production by Mac-2+ macrophages: tumor-induced population shift.

Authors:  A P Malick; K D Elgert; R E Garner; N F Adkinson
Journal:  J Leukoc Biol       Date:  1987-12       Impact factor: 4.962

Review 4.  Tumor-released microvesicles as vehicles of immunosuppression.

Authors:  Roberta Valenti; Veronica Huber; Manuela Iero; Paola Filipazzi; Giorgio Parmiani; Licia Rivoltini
Journal:  Cancer Res       Date:  2007-04-01       Impact factor: 12.701

5.  Human tumor-released microvesicles promote the differentiation of myeloid cells with transforming growth factor-beta-mediated suppressive activity on T lymphocytes.

Authors:  Roberta Valenti; Veronica Huber; Paola Filipazzi; Lorenzo Pilla; Gloria Sovena; Antonello Villa; Alessandro Corbelli; Stefano Fais; Giorgio Parmiani; Licia Rivoltini
Journal:  Cancer Res       Date:  2006-09-15       Impact factor: 12.701

6.  TLR2-mediated expansion of MDSCs is dependent on the source of tumor exosomes.

Authors:  Xiaoyu Xiang; Yuelong Liu; Xiaoyin Zhuang; Shuangqin Zhang; Sue Michalek; Douglas D Taylor; William Grizzle; Huang-Ge Zhang
Journal:  Am J Pathol       Date:  2010-08-27       Impact factor: 4.307

7.  Prostaglandin E2 promotes tumor progression by inducing myeloid-derived suppressor cells.

Authors:  Pratima Sinha; Virginia K Clements; Amy M Fulton; Suzanne Ostrand-Rosenberg
Journal:  Cancer Res       Date:  2007-05-01       Impact factor: 12.701

8.  Tumor exosomes inhibit differentiation of bone marrow dendritic cells.

Authors:  Shaohua Yu; Cunren Liu; Kaihong Su; Jianhua Wang; Yuelong Liu; Liming Zhang; Chuanyu Li; Yingzi Cong; Robert Kimberly; William E Grizzle; Carla Falkson; Huang-Ge Zhang
Journal:  J Immunol       Date:  2007-06-01       Impact factor: 5.422

9.  Exosomes as a tumor immune escape mechanism: possible therapeutic implications.

Authors:  Thomas E Ichim; Zhaohui Zhong; Shalesh Kaushal; Xiufen Zheng; Xiubao Ren; Xishan Hao; James A Joyce; Harold H Hanley; Neil H Riordan; James Koropatnick; Vladimir Bogin; Boris R Minev; Wei-Ping Min; Richard H Tullis
Journal:  J Transl Med       Date:  2008-07-22       Impact factor: 5.531

10.  More insights into the immunosuppressive potential of tumor exosomes.

Authors:  Veronica Huber; Paola Filipazzi; Manuela Iero; Stefano Fais; Licia Rivoltini
Journal:  J Transl Med       Date:  2008-10-30       Impact factor: 5.531

View more
  13 in total

1.  Differential expression of Rab27A/B correlates with clinical outcome in hepatocellular carcinoma.

Authors:  Wei-Wei Dong; Quan Mou; Jian Chen; Jian-Tao Cui; Wen-Mei Li; Wen-Hua Xiao
Journal:  World J Gastroenterol       Date:  2012-04-21       Impact factor: 5.742

2.  Molecular pathways: tumor-derived microvesicles and their interactions with immune cells in vivo.

Authors:  Ferdinando Pucci; Mikael J Pittet
Journal:  Clin Cancer Res       Date:  2013-02-20       Impact factor: 12.531

Review 3.  The roles of tumor-derived exosomes in cancer pathogenesis.

Authors:  Chenjie Yang; Paul D Robbins
Journal:  Clin Dev Immunol       Date:  2011-11-30

4.  Rab27b is a potential predictor for metastasis and prognosis in colorectal cancer.

Authors:  Jun Bao; Yijiang Ni; Hui Qin; Li Xu; Zhijun Ge; Feng Zhan; Huijun Zhu; Jiabi Zhao; Xiaoli Zhou; Xiaojun Tang; Liming Tang
Journal:  Gastroenterol Res Pract       Date:  2014-12-16       Impact factor: 2.260

Review 5.  Tumor-Related Exosomes Contribute to Tumor-Promoting Microenvironment: An Immunological Perspective.

Authors:  Wuzhen Chen; Jingxin Jiang; Wenjie Xia; Jian Huang
Journal:  J Immunol Res       Date:  2017-05-31       Impact factor: 4.818

Review 6.  Roles of Myeloid-Derived Suppressor Cell Subpopulations in Autoimmune Arthritis.

Authors:  Min Li; Dongwei Zhu; Tingting Wang; Xueli Xia; Jie Tian; Shengjun Wang
Journal:  Front Immunol       Date:  2018-12-04       Impact factor: 7.561

Review 7.  Tumor-derived exosomes, myeloid-derived suppressor cells, and tumor microenvironment.

Authors:  Xinyu Tian; Han Shen; Zhiyang Li; Tingting Wang; Shengjun Wang
Journal:  J Hematol Oncol       Date:  2019-08-22       Impact factor: 17.388

8.  Overexpression of the secretory small GTPase Rab27B in human breast cancer correlates closely with lymph node metastasis and predicts poor prognosis.

Authors:  Jia-Xing Zhang; Xiao-Xia Huang; Man-Bo Cai; Zhu-Ting Tong; Jie-Wei Chen; Dong Qian; Yi-Ji Liao; Hai-Xia Deng; Ding-Zhun Liao; Ma-Yan Huang; Yi-Xin Zeng; Dan Xie; Shi-Juan Mai
Journal:  J Transl Med       Date:  2012-12-05       Impact factor: 5.531

Review 9.  The Potential Biomarkers and Immunological Effects of Tumor-Derived Exosomes in Lung Cancer.

Authors:  Shamila D Alipoor; Esmaeil Mortaz; Mohammad Varahram; Mehrnaz Movassaghi; Aletta D Kraneveld; Johan Garssen; Ian M Adcock
Journal:  Front Immunol       Date:  2018-04-18       Impact factor: 7.561

Review 10.  Exosomes in melanoma: a role in tumor progression, metastasis and impaired immune system activity.

Authors:  Marco Tucci; Francesco Mannavola; Anna Passarelli; Luigia Stefania Stucci; Mauro Cives; Franco Silvestris
Journal:  Oncotarget       Date:  2018-04-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.